Medicine and Dentistry
Urology
100%
Urethroplasty
90%
Artificial Urinary Sphincter
88%
Urethra Stenosis
82%
Disease
82%
Urologist
67%
Stricture
65%
Surgery
61%
Recurrent Disease
59%
Surgeon
58%
Prostatectomy
58%
Malignant Neoplasm
48%
Body Mass Index
48%
Reoperation
42%
Anatomy
41%
Injury
40%
Stone Formation
40%
Kidney Stone
39%
Prostate Cancer
37%
Odds Ratio
35%
Surgical Technique
32%
Antibiotics
29%
Urination
29%
Bladder Cancer
28%
Kidney Injury
28%
Urinary System
27%
Stress Incontinence
27%
Quality of Life
27%
Public Health
27%
Bladder
27%
Operation Duration
27%
Robot-Assisted Surgery
26%
Penile prosthesis
26%
Nuclear Magnetic Resonance
26%
Bladder Augmentation
26%
Isotopes of Calcium
26%
Prostate Biopsy
26%
Replantation
26%
Urethrography
26%
Urinary Tract Infection
25%
Quality Improvement
25%
Biopsy
25%
Bleeding
25%
Outpatient
24%
Prevalence
21%
Infection
21%
Buccal Mucosa
18%
Prosthesis
18%
Transurethral Resection
18%
Minimally Invasive Surgery
18%
Keyphrases
Artificial Urinary Sphincter
54%
Urethroplasty
48%
United States
44%
Surgical Treatment
34%
Urethral Stricture Disease
34%
Risk Factors
32%
Urologists
31%
Prostate Cancer
28%
Body Mass Index
28%
Obesity
27%
Robotics
26%
Reoperation
26%
Postoperative Outcomes
24%
Surgeons
22%
Patient Characteristics
22%
Radical Prostatectomy
21%
Urinary Tract Infection
21%
GoFundMe
17%
Benign Prostatic Hyperplasia
15%
National Cancer Database
15%
Urology
15%
Stricture Recurrence
15%
Multivariable
15%
Patient Satisfaction
15%
Explantation
15%
Nephrolithiasis
14%
Multi-institutional
14%
Minimally Invasive Prostatectomy
13%
Crowdfunding Platforms
13%
Fellowship Director
13%
Catheter
13%
Patient Preference
13%
Oral Antibiotics
13%
Bladder Cancer
13%
Midurethral Sling
13%
Appendicovesicostomy
13%
Radiation Exposure
13%
State Insurance Mandates
13%
Predatory Journals
13%
30-day Mortality
13%
State Analysis
13%
Treatment Paradigms
13%
Ureteral Repair
13%
Glitazones
13%
Incidence Risk
13%
Kidney Stone Formation
13%
Urethral Hemangioma
13%
Health-related Quality of Life
13%
Risk Outcomes
13%
Neoadjuvant Chemotherapy
13%